Lupin (Peptide Division)

Indian multinational pharma company with a dedicated peptide API business. GMP-certified manufacturing. Develops and supplies generic peptide APIs and peptide-based drug products for regulated markets. Publicly traded (BSE: 500257).

Lupin (Peptide Division) is listed as a manufacturer in the peptide supply chain, serving Asia markets from India. As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. Verification is supported by 1 independent source, including documentation review and cross-referencing against public records. This supplier has a strong confidence score, indicating a high level of verification and reliability for B2B sourcing.